Previous studies have shown that yoga therapy and lifestyle modifications have improved heart failure patients’ quality of life and enhanced their cardiovascular function.
Royalty Pharma pays Ferring $300M for 5% royalty on sales of cancer gene therapy Adstiladrin
Ferring Pharmaceuticals is pulling in $300 million and a potential $200 million milestone from Royalty Pharma in exchange for a 5.1% percentage royalty on net